- Reuters•11 days ago
Dividend yields at British mining companies have hit a five-year low just as cash flows in the sector improve, prompting some analysts to call for higher payouts as early as next year. Free cash flow yield, a measure of balance sheet health, is poised to rise to 7.1 percent for major miners next year. Dividend yields are forecast to almost double to 3.6 percent, according to Credit Suisse.
- Reuters•7 months ago
An Indian court on Tuesday granted interim injunction to U.S. drugmaker Abbott's India unit , and domestic companies Glenmark Pharmaceuticals and Macleods Pharmaceuticals, on the prohibition on sale of several combination drugs. The judge in the Delhi High court granted an interim stay to the pharmaceutical companies and said regulators should take "no coercive steps" against them.
- Reuters•last year
Indian drugmaker Glenmark Pharmaceuticals is counting on strong growth in the United States, where it will launch a dozen new medicines, to offset weakness in emerging markets this year, its chief executive said. One of India's top 10 drugmakers by sales, Glenmark has seen its profit hit in recent quarters by currency volatility in Russia, Venezuela and other emerging markets, after a steep decline in oil prices and China's devaluation of the yuan. "Our U.S. business right now is more than compensating for the hit we are taking in emerging markets," Glenn Saldanha said on the sidelines of the company's annual general meeting in Mumbai.
Glenmark Pharmaceuticals Ltd. (GLENMARK.NS)
NSE - NSE Delayed Price. Currency in INR
|Day's Range||898.55 - 926.55|
|52wk Range||671.10 - 1,074.90|
|1y Target Est||N/A|
|P/E Ratio (ttm)||35.76|
|Avg Vol (3m)||548,067|
|Dividend & Yield||N/A (N/A)|